Evidence-Based Clinical Guidelines for Chronic Diarrhea 2023
Eikichi Ihara,Noriaki Manabe,Hidenori Ohkubo,Naotaka Ogasawara,Haruei Ogino,Kazuki Kakimoto,Motoyori Kanazawa,Hidejiro Kawahara,Chika Kusano,Shiko Kuribayashi,Akinari Sawada,Tomohisa Takagi,Shota Takano,Toshihiko Tomita,Toshihiro Noake,Mariko Hojo,Ryota Hokari,Tatsuhiro Masaoka,Tomohiko Machida,Noboru Misawa,Yoshiyuki Mishima,Hiroshi Yajima,Sayuri Yamamoto,Hiroshi Yamawaki,Tatsuya Abe,Yasumi Araki,Kunio Kasugai,Takeshi Kamiya,Akira Torii,Atsushi Nakajima,Koji Nakada,Shin Fukudo,Yasuhiro Fujiwara,Hiroto Miwa,Hiromi Kataoka,Akihito Nagahara,Kazuhide Higuchi
DOI: https://doi.org/10.1159/000541121
2024-08-28
Digestion
Abstract:The Japan Gastroenterological Association (JGA) published the first version of clinical guidelines for chronic diarrhea 2023. These guidelines describe the definition, classification, diagnostic criteria, diagnostic testing methods, epidemiology, pathophysiology, and treatment of chronic diarrhea, and provide flowcharts for the diagnosis and treatment of chronic diarrhea based on the latest evidence. Treatment for chronic diarrhea begins by distinguishing secondary chronic constipation with a clear etiology, such as drug-induced diarrhea, food-induced diarrhea, systemic disease-associated diarrhea, infection-associated diarrhea, organic disease-associated diarrhea, and bile acid diarrhea. The first line of treatment for chronic diarrhea in the narrow sense, defined in these guidelines as functional diarrhea in routine medical care, is lifestyle modification and dietary therapy. The first medicines to be considered for oral treatment are probiotics for regulating the gut microbiome and antidiarrheals. Other medications, such as 5HT3 receptor antagonists, anticholinergics, Kampo medicine, psychotherapy, antibiotics, bulking agents, adrenergic agonists, and somatostatin analogues, lack sufficient evidence for their use, highlighting a challenge for future research. This Clinical Guidelines for Chronic Diarrhea 2023, which provides the best clinical strategies for treating chronic diarrhea in Japan, will also be useful for medical treatment worldwide.